Down 56% over one year, AB Science stock rebounds by nearly 10% after its results
The Paris-based biotech company rebounds sharply during trading and ranks among the best performers on the market. This renewed activity comes ahead of an information meeting organized by the company.
A rebound of 9.84% that remains below all its moving averages
AB Science stock gains 9.84% to €0.60 against €0.55 the previous day, placing it in fourth position among rises in the CAC All Shares. The stock thus gains 12.3% over the week, but remains below its MA20 (€0.63, gap of 4.29%), its MA50 (€0.69, gap of 12.61%) and its MA200 (€0.99, gap of 39.09%). After a decline of 17.7% over three months and 56% over one year, today's rebound only partially reduces the quarterly decline.
The RSI at 37 is neutral. The support at €0.52 and the resistance at €0.74 frame the current trading range.
An information meeting on October 14 following a semester marked by a tax provision
In a press release published on October 12, the company announced a web conference scheduled for October 14 to present its guidance, including its "new perspectives and ambitions". This meeting follows a few days after the publication of its half-yearly accounts: the net loss of €9 million in the first half of 2026 was increased by a provision relating to the Research Tax Credit, in the dispute between the group and the tax authorities. At the end of September, the company revised its clinical calendar following an inspection of good clinical practices, and the stock had then lost 14.5%.
